Multiple factors contribute to adherence, including discontinuation due to side effects, ineffectiveness, drug shortages, employer coverage and out-of-pocket costs
FDA green-lights tirzepatide, marketed as zepbound, for chronic weight management
Additionally, for those seeking professional guidance, Prevention Clinics in New Jersey , specifically in Bergen County, Passaic County, Hackensack, and Paramus , provide expert supervision in medical weight loss treatments, including Mounjaro and Zepbound
Patients taking tirzepatide often see improvements in multiple risk factors simultaneously: weight loss, better blood sugar control, lower blood pressure, and improved cholesterol
You can receive a free virtual consultation with our doctor and get a prescription for Wegovy or Zepbound without ever leaving your home